SMPDB ID,Pathway Name,Pathway Subject,Metabolite ID,Metabolite Name,HMDB ID,KEGG ID,ChEBI ID,DrugBank ID,CAS,Formula,IUPAC,SMILES,InChI,InChI Key
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000414,Adenosine triphosphate,HMDB0000538,C00002,15422,DB00171,56-65-5,C10H16N5O13P3,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",ZKHQWZAMYRWXGA-KQYNXXCUSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000164,Pyruvic acid,HMDB0000243,C00022,32816,DB00119,127-17-3,C3H4O3,2-oxopropanoic acid,CC(=O)C(O)=O,"InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)",LCTONWCANYUPML-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000463,Hydrogen carbonate,HMDB0000595,C00288,17544,,71-52-3,CHO3,hydrogen carbonate,OC([O-])=O,"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1",BVKZGUZCCUSVTD-UHFFFAOYSA-M
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001034,Adenosine diphosphate,HMDB0001341,C00008,16761,,58-64-0,C10H15N5O10P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",XTWYTFMLZFPYCI-KQYNXXCUSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001104,Phosphate,HMDB0001429,C00009,18367,"",14265-44-2,O4P,phosphate,[O-]P([O-])([O-])=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3",NBIIXXVUZAFLBC-UHFFFAOYSA-K
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000148,Oxalacetic acid,HMDB0000223,C00036,30744,,328-42-7,C4H4O5,2-oxobutanedioic acid,OC(=O)CC(=O)C(O)=O,"InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)",KHPXUQMNIQBQEV-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000020,Biotin,HMDB0000030,C00120,15956,DB00121,58-85-5,C10H16N2O3S,"5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",YBJHBAHKTGYVGT-ZKWXMUAHSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001027,Manganese,HMDB0001333,C19610,29035,,16397-91-4,Mn,manganese(2+) ion,[Mn++],InChI=1S/Mn/q+2,WAEMQWOKJMHJLA-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000122,L-Lactic acid,HMDB0000190,C00186,422,,79-33-4,C3H6O3,(2S)-2-hydroxypropanoic acid,C[C@H](O)C(O)=O,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1",JVTAAEKCZFNVCJ-REOHCLBHSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000721,NAD,HMDB0000902,C00003,15846,,53-84-9,C21H28N7O14P2,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BAWFJGJZGIEFAR-NNYOXOHSSA-O
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001144,NADH,HMDB0001487,C00004,16908,DB00157,58-68-4,C21H29N7O14P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",BOPGDPNILDQYTO-NNYOXOHSSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C040034,Hydrogen Ion,HMDB0059597,C00080,15378,,,H,hydron,[H+],InChI=1S/p+1,GPRLSGONYQIRFK-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000180,Phosphoenolpyruvic acid,HMDB0000263,C00074,44897,DB01819,138-08-9,C3H5O6P,2-(phosphonooxy)prop-2-enoic acid,OC(=O)C(=C)OP(O)(O)=O,"InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)",DTBNBXWJWCWCIK-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000423,Magnesium,HMDB0000547,C00305,18420,DB01378,22537-22-0,Mg,magnesium(2+) ion,[Mg++],InChI=1S/Mg/q+2,JLVVSXFLKOJNIY-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000457,Potassium,HMDB0000586,C00238,29103,DB01345,24203-36-9,K,potassium(1+) ion,[K+],InChI=1S/K/q+1,NPYPAHLBTDXSSS-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000986,Guanosine triphosphate,HMDB0001273,C00044,15996,,86-01-1,C10H16N5O14P3,"({[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",XKMLYUALXHKNFT-UUOKFMHZSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000936,Guanosine diphosphate,HMDB0001201,C00035,17552,,146-91-8,C10H15N5O11P2,"[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",QGWNDRXFNXRZMB-UUOKFMHZSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001316,Carbon dioxide,HMDB0001967,C00011,16526,"",124-38-9,CO2,methanedione,O=C=O,InChI=1S/CO2/c2-1-3,CURLTUGMZLYLDI-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000101,L-Malic acid,HMDB0000156,C00149,30797,"",97-67-6,C4H6O5,(2S)-2-hydroxybutanedioic acid,O[C@@H](CC(O)=O)C(O)=O,"InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1",BJEPYKJPYRNKOW-REOHCLBHSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001010,D-Lactic acid,HMDB0001311,C00256,42111,DB03066,10326-41-7,C3H6O3,(2R)-2-hydroxypropanoic acid,C[C@@H](O)C(O)=O,"InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m1/s1",JVTAAEKCZFNVCJ-UWTATZPHSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000964,FAD,HMDB0001248,C00016,16238,DB03147,146-14-5,C27H33N9O15P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy})phosphinic acid",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",VWWQXMAJTJZDQX-UYBVJOGSSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000841,S-Lactoylglutathione,HMDB0001066,C03451,15694,,25138-66-3,C13H21N3O8S,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(2R)-2-hydroxypropanoyl]sulfanyl}ethyl]carbamoyl}butanoic acid,C[C@@H](O)C(=O)SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,"InChI=1S/C13H21N3O8S/c1-6(17)13(24)25-5-8(11(21)15-4-10(19)20)16-9(18)3-2-7(14)12(22)23/h6-8,17H,2-5,14H2,1H3,(H,15,21)(H,16,18)(H,19,20)(H,22,23)/t6-,7+,8+/m1/s1",VDYDCVUWILIYQF-CSMHCCOUSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001420,Water,HMDB0002111,C00001,15377,,7732-18-5,H2O,water,O,InChI=1S/H2O/h1H2,XLYOFNOQVPJJNP-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000080,Glutathione,HMDB0000125,C00051,16856,DB00143,70-18-8,C10H17N3O6S,(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1",RWSXRVCMGQZWBV-WDSKDSINSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001005,Zinc (II) ion,HMDB0001303,C00038,29105,DB01593,23713-49-7,Zn,zinc(2+) ion,[Zn++],InChI=1S/Zn/q+2,PTFCDOFLOPIGGS-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000905,Pyruvaldehyde,HMDB0001167,C00546,17158,DB03587,78-98-8,C3H4O2,2-oxopropanal,CC(=O)C=O,"InChI=1S/C3H4O2/c1-3(5)2-4/h2H,1H3",AIJULSRZWUXGPQ-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C002750,D-Lactaldehyde,HMDB0006458,C00937,17167,,3946-09-6,C3H6O2,(2R)-2-hydroxypropanal,C[C@@H](O)C=O,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3/t3-/m1/s1",BSABBBMNWQWLLU-GSVOUGTGSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001765,Lactaldehyde,HMDB0003052,C00424,18041,DB03776,598-35-6,C3H6O2,2-hydroxypropanal,[H]C(=O)C(C)O,"InChI=1S/C3H6O2/c1-3(5)2-4/h2-3,5H,1H3",BSABBBMNWQWLLU-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001051,Hydrogen,HMDB0001362,C00282,18276,,1333-74-0,H2,,[H][H],InChI=1S/H2/h1H,UFHFLCQGNIYNRP-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001252,Propylene glycol,HMDB0001881,C00583,16997,DB01839,57-55-6,C3H8O2,"propane-1,2-diol",CC(O)CO,"InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3",DNIAPMSPPWPWGF-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000143,NADP,HMDB0000217,C00006,18009,,53-59-8,C21H29N7O17P3,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",XJLXINKUBYWONI-NNYOXOHSSA-O
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000146,NADPH,HMDB0000221,C00005,16474,"",53-57-6,C21H30N7O17P3,"{[(2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[({[({[(2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1",ACFIXJIJDZMPPO-NCHANQSKSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000769,Lipoamide,HMDB0000962,C00248,17460,,940-69-2,C8H15NOS2,"5-(1,2-dithiolan-3-yl)pentanamide",NC(=O)CCCCC1CCSS1,"InChI=1S/C8H15NOS2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H2,9,10)",FCCDDURTIIUXBY-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C002986,S-Acetyldihydrolipoamide-E,HMDB0006878,C16255,50623,,,C10H19NO2S2,8-(acetylsulfanyl)-6-sulfanyloctanamide,CC(=O)SCCC(S)CCCCC(N)=O,"InChI=1S/C10H19NO2S2/c1-8(12)15-7-6-9(14)4-2-3-5-10(11)13/h9,14H,2-7H2,1H3,(H2,11,13)",WXCOTNFMLYTGPZ-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000782,Dihydrolipoamide,HMDB0000985,C00579,17694,,3884-47-7,C8H17NOS2,"6,8-disulfanyloctanimidic acid",OC(=N)CCCCC(S)CCS,"InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)",VLYUGYAKYZETRF-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001099,Coenzyme A,HMDB0001423,C00010,1146900,,85-61-0,C21H36N7O16P3S,"{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS,"InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14-,15-,16+,20-/m1/s1",RGJOEKWQDUBAIZ-IBOSZNHHSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000940,Acetyl-CoA,HMDB0001206,C00024,15351,,72-89-9,C23H38N7O17P3S,"{[(2R,3S,4R,5R)-2-({[({[(3R)-3-[(2-{[2-(acetylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-5-(6-amino-9H-purin-9-yl)-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,"InChI=1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/t13-,16-,17-,18+,22-/m1/s1",ZSLZBFCDCINBPY-ZSJPKINUSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001441,Phosphoric acid,HMDB0002142,C00009,26078,,7664-38-2,H3O4P,phosphoric acid,OP(O)(O)=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)",NBIIXXVUZAFLBC-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000911,Malonyl-CoA,HMDB0001175,C00083,15531,DB04524,524-14-1,C24H38N7O19P3S,"3-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-3-oxopropanoic acid",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O,"InChI=1S/C24H38N7O19P3S/c1-24(2,19(37)22(38)27-4-3-13(32)26-5-6-54-15(35)7-14(33)34)9-47-53(44,45)50-52(42,43)46-8-12-18(49-51(39,40)41)17(36)23(48-12)31-11-30-16-20(25)28-10-29-21(16)31/h10-12,17-19,23,36-37H,3-9H2,1-2H3,(H,26,32)(H,27,38)(H,33,34)(H,42,43)(H,44,45)(H2,25,28,29)(H2,39,40,41)/t12-,17-,18-,19?,23-/m1/s1",LTYOQGRJFJAKNA-VFLPNFFSSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001142,Acetoacetyl-CoA,HMDB0001484,C00332,15345,,1420-36-6,C25H40N7O18P3S,"{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(3-oxobutanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N,"InChI=1S/C25H40N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-12,14,18-20,24,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/t14-,18-,19-,20?,24-/m1/s1",OJFDKHTZOUZBOS-XBTRWLRFSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000029,Acetic acid,HMDB0000042,C00033,15366,DB03166,64-19-7,C2H4O2,acetic acid,CC(O)=O,"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",QTBSBXVTEAMEQO-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001151,Acetylphosphate,HMDB0001494,C00227,15350,DB02897,590-54-5,C2H5O5P,(acetyloxy)phosphonic acid,CC(=O)OP(O)(O)=O,"InChI=1S/C2H5O5P/c1-2(3)7-8(4,5)6/h1H3,(H2,4,5,6)",LIPOUNRJVLNBCD-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000784,Acetaldehyde,HMDB0000990,C00084,15343,"",75-07-0,C2H4O,acetaldehyde,CC=O,"InChI=1S/C2H4O/c1-2-3/h2H,1H3",IKHGUXGNUITLKF-UHFFFAOYSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C002987,Acetyl adenylate,HMDB0006880,C05993,37666,,13015-87-7,C12H16N5O8P,"(acetyloxy)({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid",CC(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,"InChI=1S/C12H16N5O8P/c1-5(18)25-26(21,22)23-2-6-8(19)9(20)12(24-6)17-4-16-7-10(13)14-3-15-11(7)17/h3-4,6,8-9,12,19-20H,2H2,1H3,(H,21,22)(H2,13,14,15)/t6-,8-,9-,12-/m1/s1",UBPVOHPZRZIJHM-WOUKDFQISA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000170,Pyrophosphate,HMDB0000250,C00013,18361,DB04160,14000-31-8,O7P2,(phosphonooxy)phosphonate,[O-]P([O-])(=O)OP([O-])([O-])=O,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-4",XPPKVPWEQAFLFU-UHFFFAOYSA-J
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C000032,Adenosine monophosphate,HMDB0000045,C00020,16027,DB00131,61-19-8,C10H14N5O7P,"{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",UDMBCSSLTHHNCD-KQYNXXCUSA-N
SMP0000558,"Primary Hyperoxaluria II, PH2",Disease,PW_C001060,Thiamine pyrophosphate,HMDB0001372,C00068,9532,,154-87-0,C12H19N4O7P2S,"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3-thiazol-3-ium",CC1=C(CCO[P@](O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N,"InChI=1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)/p+1",AYEKOFBPNLCAJY-UHFFFAOYSA-O
